Want to join the conversation?
$EXPE 2Q15 PR: Revenue in 2Q15 was $1.6Bil vs. $1.5Bil in 2Q14. Net income attributable to Expedia, Inc. was $449.64MM, or $3.38 per diluted share, vs. $89.37MM, or $0.67 per diluted share, in 2Q14. Room night growth excluding eLong accelerated to 35% YoverY with domestic and international room nights growing 24% and 50% YoverY, respectively.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?